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cis-3,4-Methylene hexanedioic acid has been found to be a normal 
constituent of human urine. The structure was deduced from gas chroma­
tography — mass spectrometry of different derivatives and confirmed by 
organic synthesis. Both peroral and intraperitoneal administration of 
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Two p atients lacking the capability of a-oxidation (Refsum's disease) 
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method based on Porapak© was therefore developed and tested. This 
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1. INTRODUCTION 
Mankind has long been fas cinated by the vision that, if only all p arts of 
a given s ystem were known, th e fate and history of that system would be 
predictable (1-4). 
One such system is the human being himself who f or a long time has 
been the subject of investigations aimed at the complete understanding of 
all its constituent parts (5). 
Because of the bewildering complexity of the human being, in vestiga­
tions have focused on minor subsystems - one of these is the urine, a part 
of t he waste disposal system of the human body (6). 
Through the careful investigation of the waste disposal sites of an 
ancient civilization, an archaeologist may gain insight into how that 
community once lived (7). The investigation of one of the human bodys 
waste disposal systems e.çj. the urine, may in a similar way give som insight 
into how th e human body works biochemically (8-10). 
Although urine is only a part of the human waste disposal sy stem its 
complexity has forced investigators to focus on di fferent compound cla sses 
present in the urine, such as peptides (11,12), amino acids (13), carbo­
hydrates (14), steroids (15), bile acids (16), and organic acids (17), as well a s 
inorganic salts, pigments and nitrogen bases (18). The aims and results of 
the investigations of all these different compound classes were highly 
influenced by the available separation and detection methods. 
The f irst records of human urine are those dealing with its antiseptic 
and healing effects, as well as those claiming that the fate of a human 
being could in part be foreseen by the investigation of the urine (19,20). 
Analysis of human urine for diagnostic purposes has certainly been prac­
ticed earlier than the first Babylonian written reports (21), but has 
probably been of the same level of sop histication, where separation at best 
meant evaporation and detection was equal to visual inspection. It took 
several thousand years until color reactions, solvent extractions, and 
crystallisations were used for the identification and q uantitation of urinary 
compounds (8,22). Uric acid, urea, and hippuric acid are among the 
substances separated and characterized in those years when chemical 
methods were introduced for the analysis of urinary constituents (8,23). 
The separation of isolated compounds from impurities was tedious, time 
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consuming, and required large amounts of substance. The discovery of 
chromatography at the beginning of this century (24) drastically changed 
that situation, and impressive advances were made in the elucidation of 
urinary organic acids with the techniques of paper, thin layer, and column 
chromatography (17). 
After those first steps towards a more specific evaluation of the 
urinary components for diagnostic and research purposes, it took less than 
fifty years to arrive at the methods used in thi s work. 
A detailed knowledge of the qualitative and quantitative excretion 
pattern of organic acids in human urine is essential for the discovery of 
pathological metabolites of etiological and diagnostic value, especially in 
the field of inborn errors of metabolism. Knowledge about the structure 
and metabolism of the urinary constituents has increased in parallel with 
analytical advances, and such a symbiotic relationship is also reflected in 
this work, in which the main aim was to gain more knowledge about the 
acidic compounds of human urine in he alth and d isease (Papers I, II and IV). 
Whilst working with the elucidation of organic acids in human urine, some 
methodological problems were solved to suit our needs in cl inical routine 
analysis (Papers III and V). 
2. BIOLOGICAL ASPECTS AND RESULTS 
2.1 Metabolism 
It has been known fo r a very long time that some compounds appear to 
pass the body unchange d, as revealed by the odor or color of the urine after 
the ingestion of certain foods, whereas others are absorbed and utilized by 
the body (8,25). Later it was realized that ingested foods where trans­
formed by th e body and that even endogenously produced co mpounds where 
excreted (8,26). Recently it was recognized that some compounds excreted 
in the urine originate from the action of the intestinal microflora (27,28). 
The first experimental proof, that an ingested compound is trans­
formed by the human body and then excreted into the urine, was made at 
the beginning of the nineteenth century, when it was shown that ingested 
benzoic acid to a very great extent could be recovered as hippuric acid 
from the urine (29-31). Nearly seventy years later it was shown by Knoop, 
that ingested compounds may not only be conjugated but also degradated 
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by the body before they are excreted. Knoop was the first to deduce a 
metabolic pathway from the analysis of urinary metabolites: looking at the 
excreted degradation products of co-phenylcarboxylic acids fed to dogs, he 
derived the ß-oxidation sequence for fatty acids (10). In the following 
decades the ß-oxidation pathway of fatty acids in mitochondria was 
unraveled by numerous workers (32-34), leading to the scheme shown in 
Figure 1. 
R-CH2-CH2-CH2-COOH 
HSCOA-ATP 
© MS2* 
AMR-PP: 
R - C H 2 - C H 2 - C H 2 - C O C O A  
—- FAD 
© 
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© 
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RCH2COCOA 
Figure 1. Single ß-oxidation cycle with participating enzymes: 
1. Long-chain acylthiokinase (acid:CoA ligase(AMP), EC 
6.2.1.2); 2 . Acyl-CoA dehydrogenase (acyl-CoA:oxidoreductase, 
EC 1.3.2.2); 3. Enoyl-CoA hydrase (L-3-hydroxyacyl-CoA hydro 
lyase, EC 4.2.1.17); 4. ß-Hydroxyacyl-CoA dehydrogenase (L-3-
hydroxyacyl-CoA:NAD oxidoreductase, EC 1.1.1.35); 5." ß-
Ketoacyl-CoA thiolase (acyl-CoA:acetyl-CoA acyl transferase, 
EC 2.3.1.16). 
Thirty years after Knoops discovery it was shown that long chain fatty 
acids are not only oxidized by ß-oxidation but also by &o-ox idation (35), and 
another three decades later a third oxidative transformation of fatty acids, 
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a-oxidation, was discovered (36). The main purpose of the oxidative 
degradation of fatty acids by t he g-oxidation pa thway is the production of 
acetyl-CoA (Fig. 1), which may be utilized by the citric acid cycle for 
energy production. Neither co-nor a-oxidation are able to degradate fatty 
acids, and one of their functions is to make certain fatty acids amenable to 
3-oxiation when structures such as methyl branches (37), an acetylenic 
bond (38), a cyclopropane ring (39), or a 1,2-substituted aromatic ring 
(unpublished res ults) block or impair the action of t he g-oxidation enzymes. 
Typical examples for this role of t he co-oxidation system are the oxidative 
degradation of long chain cyclopropane fatty acids (Paper I) and of 
branched fatty acids (Paper IV). 
The urine of healthy subjects and patients with different disorders was 
found t o contain cis-3,4-methylene hexanedioic acid. The structure of this 
compound was elucidated from the mass spectra of different derivatives 
and by organic synthesis (I). 
Rats, given both radioactively labeled and unlabeled cis-9,10-
methylene octadecanoic acid perorally, excreted both labeled and un­
labeled 3,4-methylene hexanedioic acid and homologues with six, eight, and 
nine carbon atoms in the urine (I). A schematic drawing of the possible 
oxidative degradation of cis-9,10-methylene octadecanoic acid is shown in 
Figure 2. 
COOH 
9,10-Methylene Octadecanoic Acid 
UJ - oxidation 
9,10 -Methylene Octadecanedioic Acid 
HOOC vTvT' COOH 
x - oxidation 
uJ - oxidation 
8, 9 - Methylene Heptadecanedioic Acid 
HOOC 
COOH 
5x • oxidation 5 x ft -oxidation 
"Co 
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HOOC v/^\/V C00H 
! 
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/ 
3,4 - Methylene Hexanedioic Acid 
' C7 HOOC COOH 
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3,4 - Methylene Heptanedioic Acid 
HOOC . /X XN C00H 
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2,3 - Methylene Pentanedioic Acid 
HOOC 
COOH 
"C8" 
main metabolite 
Figure 2. Oxidative degradation of 9,10-methylene octade­
canoic acid. 
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Intraperitoneal administration of cis-9,10-methylene octadecanoic 
acid to rats led to the excretion of the same metabolites, although at a 
slower rate than after oral administration. The fact, that both oral and 
intraperitoneal administration of 9,10-methylene octadecanoic acid yields 
the same metabolites, supports the view that the short-chain cyclopropane 
dicarboxylic acids are degradation metabolites from the mammalian 
organism, and not fr om gut bacteria (I). 
The gastrointestinal uptake of cis-9,10-methylene octanoic acid is 
comparable to the uptake of stearic acid as shown in Figure 3 by the 
recovery of both acids from the lymph of thoracic duct cannulated rats (I). 
10 
61 •/« 
5 
9-21 21-30 30-92 
SAMPLING INTERVALS [h] 
Figure 3. Amount of radioactivity recovered in r at lymph a s a 
per cent of the given amount of f9,10-^H?]cis-9,10-methylene 
octadecanoic acid methyl ester and fl-^Cjstearic acid, respec­
tively. 
No metabolic pathway to generate cyclopropane fatty acids has been 
found in mammals, but long-chain cyclopropane fatty acids are formed in 
bacteria (40) and certain plants (41). The excretion of cis-3,4-methy!ene 
hexanedioic acid found in human urine is therefore most probably due to 
intestinal absorption of long chain cyclopropane fatty acids. 
It is known that a cyclopropane ring incorporated into a long-chain 
fatty acid can be degradated completely by the oxidative enzymes of 
microorganisms (42). The large amount of tritiated water found after 
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administration of 9,10-3H2j£is-9,10-methylene octadecanoic acid to rats 
(Fig. 4) may indicate the total degradation of the cyclopropane ring but is 
in c ontrast to previous findings where no d egradation of the cyclopropane 
ring has been de tected in mammals (39,43). 
Although ab out 70% of the ingested cyclopropane fatty acids may be 
excreted as short-chain carboxylic acids, a minor amount seems to be 
incorporated into body lipids as shown in Figure 4 by the radioactivity 
recovered from the rat carcass (I). 
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U R !  
LAYER 
NE 
WATER LAYER 
C A R f  
ORGANIC LAYER 
:ass 
WATER LAYER 
rf] r1] 
ji) 
ifc i  
H 
n 
A* 
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Figure 4. Radioactivity (% of given dose, mean and range of 
two experiments) from rats fed [9,10-^H7jcis-9,10-methylene 
octadecanoic acid methyl ester, and killed after one (A), two 
(B), and three (C) days. 
The shaded areas denote the amount of labeled water found 
after distillation; the difference is nonvolatile residue. 
It has been shown that D-aspartic acid accumulates in brain tissues 
with age (44). If cyclopropane f atty acids are accumulated in a similar way 
in different cell membranes during a lifetime, a higher rigidity and 
stability of those membranes could be expected (45,46), which might 
contribute to the ageing of some tissues. 
The excretion of the metabolite described in P aper I, 3,4-methylene 
hexanedioic acid, does not depend on the state of health. 2,6-Dimethyl-
octanedioic acid, the dicarboxylic acid reported in Paper IV , on the other 
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hand is only detected in the urine of patients with a rare metabolic 
disorder, Refsum's disease. 
Phytanic acid, formed from phytol ingested with plant-derived foods 
(47), can not be oxidized by th e ß-oxidation system until oxidized at carbon 
atom two by a-oxidation (48) as shown in Figure 5. 
/WwWV™" 
Phytanic Acid 
• oxidation (X - oxidation vf t i E S Block in Refsum's disease 
Pristanic Acid 
. C02 
COOH 
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HOOC x\/x aAÀAÀ, COOH 
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V 
2,6 - Dimethyloctanedioic Acid 
HOOC 9^ ^  • C00H 
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3 - Methyladipic Acid 
HOOC AÅs C00H 
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Methylsuccinic Acid 
„ I  COOH 
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Figure 5. Oxidative degradation of phytanic acid. 
In R efsum's disease (49) a-oxidation h as been shown to be absent (50), 
leading to an accumulation of phytanic acid in different tissues. The 
accumulated phytanic acid impairs the normal neural functions causing 
symptoms such as blindness, deafness, and loss of movement control in the 
extremities (49). 
As shown by the excretion of 2,6-dimethylocatanedioic acid, phytanic 
acid can also be made accesible to 3-oxidation by an initial ^-oxidation. 
Unfortunately the capacity of this minor pathway is not sufficient to 
prevent an accumulation of phytanic acid, if t he dietary intake of phytol is 
not restricted. 
16 
In the formation of 3,4-methylene hexanedioic acid (I) and of 2,6-
dimethyloctanedioic acid (IV) CD-oxidat ion becomes important because of 
structures blocking the B-oxidation system. Lù -Oxidation also becomes 
important when changes of the normal metabolism occur, as in ketogenic 
conditions. An e xample for this is the dicarboxylic acid described in Paper 
II, 3-hydroxydecanedioic acid, another dicarboxylic acid normally found in 
human urine. In healthy subjects only minimal amounts are found, but in 
ketoacidosis a fifty-fold increase in the excretion may be found, reaching 
up to 400 Umol/1 of urine (II). 
It has been shown that endogeneously produced adipic acid - also a 
normal constituent of urine - is excreted in much higher amounts in 
ketoacidosis of different etiology (51). The excretion of 3-hydroxydecane­
dioic acid correlates positively with the excretion of adipic acid in 
ketoacidosis supporting the view, that 3-hydroxydecanedioic acid is of 
endogeneous origin. The finding, that even saturated and unsaturated 
homologues of 3-hydroxydecanedioic acid with eight, twelve, and fourteen 
carbon atoms can be detected in ketoacidosis (II), is a strong indication for 
an accumulation caused by an overloading of the ß-oxidation system. This 
shows that in spite of t he activation observed for the oxidative degradation 
of fatty acids in k etotic conditions (52-56), the capacity of the 3-oxidation 
system is not sufficient to cope with the increased availability of long and 
medium chain fatty acids in ketoacidosis. 
2.2 Diagnosis 
Already in those times, from which no written records can be found, 
"physicians" may have noticed urines that have a sweet taste, turn dark on 
storage, or have a peculiar odor, without knowing the nature or the 
metabolic origin of the compounds leading to the observed deviations from 
normal urines. A modern physician would h ave realized that these patients 
may suffer from diabetes mellitus, alcaptonuria, or possibly 
phenylketonuria. 
The chemical nature of the compounds leading to these peculiarities of 
the urine of certain patients have been identified. Thus, in 1815 glucose 
was identified in the urine of patients with diabetes mellitus (57), in 1891 
homogentisic acid was shown to be the compound leading to the darkening 
of the urine of patients with alkaptonuria (58), and in 1934 phenylpyruvic 
acid was identified in the urine of patients now known to suffer from 
phenylketonuria (59). 
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Among the above mentioned diseases alkaptonuria was one of the 
disorders for which the term "inborn error of metabolism" was coined by 
Garrod (60). The concept of the inborn errors of metabolism and the 
development of the chromatographic methods, especially paper chromato­
graphy, lead to the discovery of several errors of amino acids and 
carbohydrate metabolism (13,14). Later the development of gas chromato­
graphy and especially gas chromatography-mass spectrometry and their 
application to the analysis of organic acids in blood and urine (61) led to 
the discovery of several inborn errors of metabolism such as isovaleric 
acidemia (62), methylmalonic aciduria (63), propionic acidemia (64), pyro-
glutamic aciduria (65), and 3-methylcrotonylglycinuria (66,67). 
Metabolic diseases may be detected because of the secondary effects 
of the underlying genetic disorders, even if the exact genetic location and 
nature of the defect are not known (68-70). The genetic defect may lead to 
increased concentrations of metabolites detectable in amniotic fluid, 
blood, or even urine of the mother, or may be measured as deficient or 
impaired enzymatic activity in fetal cell cultures (71). Examples of inborn 
errors detected prenataly in this way are methylmalonic aciduria (72-74), 
maple syrup urine disease (75,76), propionic acidemia (77,78), 3-hydroxy-3-
methylglutaric aciduria (79,80), glutaric aciduria type I (81), and tyro-
sinemia (82-84). 
The pre- and post-natal diagnosis of the above mentioned metabolic 
disorders leading to abnormal excretion patterns, rely in part on the 
techniques discussed in t he following methodological part of this presenta­
tion. 
3. METHODOLOGICAL ASPECTS AND RESULTS 
3.1 Collection 
Already in ancient times physicians knew that the time of collection 
and storage time of the urine had an effect on the examination results (20). 
The use of freshly cast morning urine was already advocated in the middle 
ages as being best for analysis (85), and is still regarded as optimal for 
analysis, when the total daily amount excreted is not needed for analysis 
(86). 
The analysis should be performed as soon a s possible af ter collection 
and no preservatives should be added, except when this is required for 
special analyses. If sto rage or transport are unavoidable the urine should be 
kept frozen until analyzed to prevent bacterial growth or chemical 
decomposition. 
3.2 Isolation 
The simplest non-selective isolation method for the soluble compounds 
of th e human urine - sediments are not dealt with in th is presentation - is 
the evaporation of urinary water (8). Precipitation (87) may give better 
selectivity, but the most selective isolation methods are all based on the 
partition equilibria of the dissolved uri nary compounds with a solid, liquid, 
or gaseous phase. 
Purging the urine with an inert gas and subsequent trapping of the 
compounds carried over is still the method of choice for the analysis of 
volatile compounds (88-90), although a method for the direct separation 
and detection of volatiles in aqeous samples has been published (91). 
The oldest method for the isolation of the non-volatile urinary organic 
acids, based on liquid-liquid partition equilibri a (92), is still the most widely 
used because of its simplicity and speed (93,94). Methods depending on 
liquid-solid partition equilibria have traditionally been based on oxidized 
silica or alumina to adsorb the non-volatile solutes (95-98). Now a large 
number of workers use ionic and non-ionic organi c polymeric materials to 
isolate organic acids from human urine (93,94). 
When our laboratory started analyzing urinary organic acids for 
metabolic screening in late 1974, the solvent extraction method was 
adopted. Because of the known limitations of the solvent extraction 
method to recover very polar acidic compounds (99,100) we started to 
search for a better isolation method amenable to automation. After a lot 
of disappointing experiments with different organic materials we started to 
evaluate the different Porapak (Trademark of Waters Ass.) ma terials, and 
developed t he isolation p rocedure presented in Paper V, which is based o n a 
1:1 by volume m ixture of Po rapak T and Por apak Q. Acidified samples are 
applied to the acid-washed columns and eluted with acetonitrile. Good 
recoveries for unpolar and polar compounds are obtained as shown in Table 
Table 1. Recovery of selected organic acids as a percent of initial 
radioactivity (mean - SD) 
Porapak Solvent extraction Ion 
exchange 
n=10 n=10 n=3 
Oxalic acid 30.6 t 5.8 31.3t 1.4 94.2 t 2.0 
Lactic acid 34.lt 5.4 22.6t 0.9 81.lt 2.4 
Succinic acid 93.61 2.2 74.0t 3.2 94.41 1.8 
2-Oxoglutaric acid 97.0 t 1.2 38.4t 2.5 83.9 t 2.2 
Citric acid 66.3 t 4.5 8.7t 0.5 85.5 t 1.1 
Cinnamic acid 94.3 t 3.1 95.4t 3.6 99.2 t 3.8 
The main advantages of the isolation of acidic compounds from urine 
with the method based on Porapak material over the solvent extraction 
method with ethyl acetate is illustrated in Figure 6. The most prominent 
features are the reduced recovery of urea and phosphoric acid (peaks 4 and 
5 in Figure 6), and the increased recovery of polar compounds e.cj. ci tric 
acid (peak 12 in Figure 6). 
The Porapak columns are regenerated by washing with acetone and 
water, and may be reused more than fifty times. Deterioration of the 
material is shown by a decreased recovery of such polar compound as the 
tetronic acids. The column material is routinely replaced once each month 
in our laboratory. 
The adsorption mechanism on the Porapak material has not been 
studied in detail but the most likely explanation is a combination of 
hydrophobic forces of the ethylvinylbenzene-dimethylbenzene co-polymer 
with hydrophilic forces of t he enclosed water molecules. 
Even compounds other than organic acids are recovered from the 
Porapak columns such as glycerol (101), 3-methylcrotonylglycine (102), 
tyrosine (V), and orotic acid (V). 
Simple separations through gradient eiution can also be achieved on 
these materials, but that possibility has not been investigated in detail. 
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Figure 6. Total ion current traces of methoxymated and sily-
lated compounds isolated from 2 mi of pooled normal urine with 
ethyl acetate extraction (EtOAc, upper trace) and with 
adsorption on Porapak^ (PTQ, lower trace). Prominent peaks 
are: 1 procedural artifact; 2 p-cresole; 3 sulfuric acid; 4 urea; 
5 phosphoric acid; 6 succinic acid; 7 pyroglutamic acid; 
8 furane-5-hydroxymethyl-2-carboxylic acid; 9 4-hydroxy-
phenylacetic acid; 10 glycylfurane-2-carboxylic acid; 
11 aconitic acid; 12 citric acid; 13 hippuric acid; 14 unidentified 
hexose; 15 uric acid; 16 3-hydroxyhippuric acid; 
17 4-hydroxyhippuric acid; 18 unidentified hexonic acid; 
19 N-phenylacetylglutamine; A 4-pentynoic acid (internal 
standard); B 3-chlorobenzoic acid (internal standard); 
ES tetracosanoic acid (external standard). 
Chromatographic conditions: 23 cm/s He carrier gas; 20 m, 
0.5 mm I.D. pyrex-glass capillary column coated with 1.2 um of 
cross linked SE-54; temperature programmed from 50°C, held 
for 2 min, up to 290°C, held for 9 min, at a rate of 7 °C/min. 
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3.3 Separation 
The early attempts to separate the soluble urinary compounds isolated 
were made by distillation, consecutive selective solvent extractions, or 
recristallisations after proper chemical modifications (8,31). A still ongoing 
revolutionary development was started with the first papers on column 
chromatographic separation (24,103-106). Other milestones were the de­
velopment of paper chromatography (107), thin layer chromatography (108-
110), and especially gas chromatography (111-115). 
Although most of the urinary organic acids may be separated in their 
native form by liquid chromatography (116,117), it is often advantageous to 
modify them chemically before chromatography is started. The chemically 
modified organic acids may give a better detection sensitivity, or may have 
better chromatographic properties. Most organic acids must be derivatized 
to increase their volatility and stability for gas chromatographic separa­
tion, which has become the accepted standard method for the analysis of 
urinary organic acids, first with packed columns (118,119), and then with 
capillary columns (93,94,120). 
A schematic illustration of a gas Chromatograph (GC) is shown in 
Figure 7 (detail G), and consists of a pressurized carrier-gas delivery 
system, a sample application port, a chromatographic column, and a 
detector. The electric signal from the detector is amplified and transferred 
to a recorder or data system. 
Capillary columns may be prepared from metals, plastics, different 
glasses, and from pure fused silica (121). Different ways to apply the 
chromatographic phase onto the unmodified or modified inner wail of the 
capillary column have been described (122). The most common is now the 
static coating method where a solution of the chromatographic phase is 
introduced into the capillary column. After the subsequent evaporation of 
the solvent the chromatographic phase remains as a thin homogeneous 
coating on the inner wall of the capillary column (123). It is essential to 
make the coating non-extractable for on-column injections, and several 
methods to stabilize the chromatographic phase by crosslinking have been 
published (124-129). A careful selection of the material and internal 
diameter of the capillary column as well as the thickness and nature of the 
coating is crucial for each application (121,122). 
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Figure 7. Schematic drawing of a combined gas Chromatograph 
- mass spectrometer. A: septumiess injection port; B: "quasi on 
column" glass-lined stainless-steel injector; C: coupling of 
empty fused silica precolumn (0.3 mm I.D.) to analytical wide 
bore (0.5 mm I.D.) pyrex glass column; D: glass-lined stainless 
steel effluent splitter; E: open-split coupling; F: flame ioniza­
tion detector; G: gas Chromatograph; H: quadrupole mass 
spectrometer; I: detail of the dead volume free connection 
used. 
Because of their higher sample capacity wide-bore capillary columns 
with a thick-film coating appeared to be the best choice for us to use in 
the routine analysis of organic acids in urine (130,131). When we started to 
analyze organic acids in urine, appropriate wide-bore capillary columns 
were not available commercially, and were therefore prepared in our 
laboratory. Although dif ferent cross-linked thick-film wide-bore capillary 
columns are now commercially available, we still prefer to prepare the 
columns in our laboratory because of economic and didactic considerations 
(132). 
The step from packed columns to wide-bore (0.5 mm I.D.) capillary 
columns i llustrated in Figure 8 was done in 1978 in our laboratory and led 
to the development of the septumless injection port described in P aper III. 
This injection port eliminated all the problems we previously had with the 
injection membrane, especially bleeding and particles torn from the 
membrane which were flushed into the capillary column, leading to a 
severe impairment of the chromatographic performance. 
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Figure 8. Comparison of packed (upper) and capillary (lower) 
column chromatogram of a patients urine after isolation, 
methoxymation, and sily lation. The arrow indicates the position 
of t he internal standard. 
The injection port (Fig. 7, detail A) was interfaced to a modified 
autosampler and fit ted with a wide bore (0.7 mm I.D.) glass-lined stainless-
steel tubing to enable "quasi on column" injection (Fig. 7, detail B). This set 
up facilitates the connection of all sorts of capillary columns to a given 
injector configuration thus eliminating the need for special on column 
injection devices. The shown set up has been in use in our laboratory for 
manual injection since 1978 and for autosampler injection since 1981 for 
both flash heated as well as cold "quasi on column" injections. 
3.4 Detection 
Before the advent of chromatographic separation techniques the 
detection of urinary constituents has since ancient times relied on the 
inspection of the urines color, transparency, odor, and taste (133,134). 
The introduction of the chromatographic techniques made it possible 
to separate a large number of urinary compounds, most of them colorless. 
The inability to detect the separated compounds while they eluted from the 
chromatographic column catalyzed the development of d ifferent detectors. 
Some of the detectors now in use in liquid column chromatography are the 
refractive index detector (135), the UV-detector (136-138), the fluores-
cense detector (139), and the electrochemical detector (140,141). 
Two ga s chromatographic detectors of historical interest are Martin's 
gas density balance, and Cook's argon detector (142). Now th e most widely 
used detector in gas chromatography has become the flame ionization 
detector (113,143-146). Other detectors used in gas chromatography are 
the thermal conductivity detector (147,148), the electron capture detector 
(149), the photoionization detector (150), and the infrared spectrometer 
(151-153). 
The UV-detector, the fluorescense detector, the electro-chemical 
detector, the electron-capture detector, the photoionization detector, and 
the infrared spectrometer can be operated to specifically detect certain 
compounds or compound classes. All other detectors mentioned have no 
special compound specificity, and are thus useful for the detection of 
nearly all urinary organic compounds. 
The most versatile detector so far developed suitable for eluents in 
liquid and gas chromatography is the mass spectrometer (154-162). The 
mass spectrometer is unique b ecause it combines high sensit ivity with the 
ability to generate very specific spectra for nearly all compounds, ei ther in 
their native state or as suitable derivatives (163-172). One disadvantage of 
the mass-spectrometric detector shared by the f lame ionization detector is 
that it is a destructive detector, and thus a compound detected with a mass 
spectrometer or a flame ionization detector can not be recovered as it was 
introduced. 
For the analysis of urinary organic acids we have chosen to evaluate 
the effluent of the gas chromatographic column with two independent 
detectors simultaneously by splitting the effluent through a glass-lined 
stainless-steel T-piece to a flame ionization detector and to a mass 
spectrometer. Details of the effluent splitter and of the slightly modified 
open-split coupling to the mass spectrometer are shown in Figure 7 (details 
D and E, respectively). 
The flame ionization detector (FID) consists of a hydrogen flame into 
which the effluent from the gas-chromatographic column is directed for 
combustion at a temperature between 1000 and 2000°C (173). At this flame 
temperature ions are formed, which can be detected by a cylindrical 
electrode surrounding the flame, and held at a potential of approximately 
300 V against ground (Figure 7, detail F). The current detected is amplified 
and recorded. Stable operating conditions are obtained for each detector 
design at certain flow rates of hydrogen gas, air and c arrier gas for a given 
temperature which should be high enough to prevent condensation of 
material eluting from the chromatographic column. 
A dynamic range of six to eight orders of magnitude may be a ttained 
depending on the detected compound (174). The lowest detectable amount 
12 for favorable detection conditions is in the order of 10 g/sec (174). This 
means that a given am ount of eluate will yield a higher detector response 
when passing the detector in a shorter period of time, as long as the time 
constants of the amplifying and recording systems are sufficiently short. 
This differential property of the flame ionization detector is shared by the 
mass-spectometric detector which has about the same sensitivity and 
dynamic range of d etection (175). 
A mass spectrometer (MS) is a d evice that generates volatile ions and 
separates them in vacuo according to their mass to charge ratio. A 
schematic diagram of a quadrupole mass spectrometer is shown in Figure 7 
(detail H). Ions produced in the source are separated in the mass analyzer 
section and accelerated against the conversion dynode of a secondary 
electron multiplier (SEM). The amplified signal from each ion hitting the 
conversion dynode is transmitted to a galvanornetric recorder or to a data 
system. Several mass spectrometric analyzers are available, but only the 
quadrupole and the magnetic sector analyzer in combination with a gas 
Chromatograph are widely used for the analysis of organic acids in urine 
(93,94,176). 
In t he ion source both positive and negative ions are formed, usually in 
favor of the positive ions by a factor of a thousand (156). For some 
electron-capturing compounds or derivatives the proportion of negative 
ions may increase considerably and their detection instead of the positive 
ions can be advantageous (177,178). Ions may be generated in several ways. 
The most common way is still the electron impact ionization with thermal 
electrons from a metal filament (often Rh). The thermal electrons are 
usually accelerated to an energy of about 70 eV. Additional ionization 
methods used are chemical ionization (179,180), fast atom bombardment 
(181,182), field ionization and field desorption (183,184), atmospheric 
pressure ionization (185), and thermo-spray ionization (186,187). Only 
electron impact and chemical ionization methods are commonly used in the 
gas chromatographic-mass spectrometric analysis of urinary organic acids. 
The combination of gas chromatography with mass spectrometry 
(GC-MS) generates some specific problems (157,175). Gas chromatography 
is a high pressure technique (about atmospheric pressure at the column 
outlet), whereas mass spectrometry depends on a very low pressure (about 
O 
10" torr in the analyzer section). Differential pumping systems have 
solved that problem. Another mismatch was, that the gas flow rate of a 
packed gas chromatographic column is in the order of 30 ml/min, whereas 
the mass spectrometer is able to handle a flow rate in the order of 3 
ml/min. Early solutions to that problem were gas separators (157), which 
have become unnecessary after the advent of capillary columns commonly 
operating at flow rates below 3 ml/min. Direct introduction of the effluent 
of the gas chromatographic capillary column into the ion source of the 
mass spectrometer is thus possible, but has the disadvantage that even 
solvents and reagents applied with the sample onto the column are pumped 
into the mass spectrometer. Column effluent diverting systems, such as the 
open-split coupling shown in Figure 7 (detail E), are therefore used in many 
laboratories (188-191). 
Another problem is that high pe rformance capillary columns are able 
to resolve about ten components per second, whereas modern mass spectro­
meters can at present only sam ple three full spectra (from m/z 50 to 800) 
of good quality per second. The chromatographic separation must thus be 
run below optimal speed which leads to a lower detectability because of 
sample adsorption and degradation, as well as because of the differential 
nature of the mass-spectrometric detector (192). This problem is not 
encountered when the mass spectrometer is operated to detect only cer tain 
ions instead of full mass spectra. 
3.5 Identification 
In t he same way as detection of urinary compounds has long relied on 
specific colors, odors, or tastes for unseparated as well as separated 
compounds, so has identification (8). 
The development of specific separation techniques such as precipita­
tion, distillation, recrystallisation, and especially chromatography enabled 
the purification of individual urinary components. Once purified a com­
pound could be identified by i ts physical and chemical properties, such as 
melting point, boiling point, chemical reactivity towards different rea­
gents, ability to give crystalline products, spectroscopic properties, ele­
mental analysis, and finally by its identity with a synthesized compound 
showing the same chemical and physical proper ties. 
Although t he combined application of physical m ethods such a s infra­
red spectrometry (IR), nuclear magnetic resonance (NMR), and mass 
spectrometry (MS) a re often sufficient to characterize a compound, the 
synthetic proof is still the most definitive (193,194). 
In the field of urinary organic acid analysis, capillary gas chromato-
graphy-mass spectrometry has become the method of choice for fast 
identification of isolated compounds, simultaneously to the chromato­
graphic separation (195). Liquid chromatography-mass spectrometry might 
become an alternative to gas chromatography - mass spectrometry because 
of some recent developments made in the coupling of liquid chromato­
graphy w ith mass spectrometry (196-198). Using the techniques of low and 
high resolution gas chromatography-mass spectrometry the knowledge 
about urinary organic acids has increased considerably during t he last ten 
years through the efforts of numerous workers (93,94,199-210). 
Because of the large amount of analytical data generated by a gas 
Chromatograph - mass spectrometer the combination with a data system 
has been essential for data reduction and evaluation (157,175,211-220). 
Nevertheless many of the early results were obtained without the help of a 
data system. Datorized gas chromatographic-mass spectrometric equip­
ment is now commercially available from a number of vendors with 
different types of mass analyzers and with a high deg ree of reliability and 
versatility. 
Although sophisticated datorized gas chromatographic-mass spectro­
metric equipment has revolutionized the identification of e.cj. organic a cids 
in urine, the analyst will always be needed because of problems with 
unresolved eluents (221), impurities (222,223) and procedural a rtifacts (224-
226). 
3.6 Quantitation 
Qualitative data are often sufficient for the correct diagnosis of a 
disease, but when comparisons, evaluation of severity, and prediction of 
outcome are to be made quantitative data are indispensable. Quantitative 
methods introduced very early were gravimetry (8,31), titration (227,228) 
and colorimetry (229) which a re still in u se parallel to the newer physical 
methods. All the detectors mentioned in th e previous section are useful for 
quantitative estimations. 
The flame ionization detector and t he mass spectrometer have gained 
worldwide acceptance for the quantitative estimation of urinary organic 
acids, and are also used in our laboratory. The following discussion will 
therefore be restricted to the methods of gas chromatography-flame 
ionization detection and gas chromatography-mass spectrometry. 
The mass spectrometric detector may be operated either in the full 
scan mode or in the single or multiple ion detection mode, usually 
computer controlled. Higher sensitivity is ob tained in t he latter operating 
mode which is thus used for qualitative and quantitative trace analysis 
(230-233). The full scan mode is used for the structure elucidation of 
unknown compounds but can be used for quantitative analysis as well, 
although with lower precision and sensitivity (234,235). 
The reliability of quantitative results depends more or less on several 
factors such as care in the preparation of samples and standards, chroma-
tographic conditions, type, condition and operating mode of the detector, 
mode of data evaluation, as well as skills and experience of the analyst. 
RnUflawjny^pWÄa^äu-recOTnrnertQäviona^TOr-godiVifeioor&tDVy^prafcvrce^Z^u-
239) will prevent the most serious errors in sample and standard handling 
procedures. The chromatographic conditions must be optimized for each 
analytical problem by t he proper choice of carrier gas, injection method, 
type of column, type of ch romatographic phase, temperature of separation, 
as well as type and temperature of the connection to the detector. 
Following the manufacturers installation, test and maintenance procedures 
for the chosen detector will in most cases be sufficient to obtain 
satisfactory quantitative results. 
Quantitative results from mass spectrometers are highly a ffected by 
improper threshold settings, which in addition may be unstable and thus 
make day to day comparisons difficult. New s tandard curves are therefore 
necessary for each measuring sequence (232). Other problems when 
attempting quantitation of complex biological samples may a rise from non 
linearity of standard curves (240,241), isotope effects (242), choice of 
internal standard (243,244), as well as instrumental set up an d measuring 
conditions (245). 
Even a correct quantitation may be difficult to interpret because of 
day to day variations in excretion (246-250), excretional changes due to 
medication (251) or diet (252), and d ifficulties with interpatient compari­
sons mainly because of creatinine excretion variances (253-260). 
4. CONCLUDING REMARKS 
A detailed knowledge of normal metabolic pathways and the variation 
of normal and pathological urinary excretion patterns is essential for the 
correct diagnosis and treatment of many inborn er rors of metabolism. 
Several computer programs for the automatic identification and 
quantitation of gas chromatographic-mass spectrometric data have been 
developed (199,212,217). Even programs for the automatic diagnosis of 
diseases based on ga s chromatographic-mass spectrometric data have been 
published (261). Unfortunately these data programs have not to a signifi­
cant extent found their way into routine clinical laboratories and seem to 
work b est in the hands of those who developed them. 
Other analytical improvements such as sophisticated combinations of 
different analytical techniques (262), e.g. gas chromatography-fourier 
transform infrared spectrometry-mass spectrometry-data system (263), 
which have a great potential for the elucidation of unknown compounds and 
can with great reliability be used to identify known ones , are to expensive 
or to complicated for routine clinical laboratories. 
It seems therefore unlikely th at the "manual" evaluation of analytical 
data for the purpose of identification and diagnosis of inborn errors of 
metabolism will be replaced by fully automated computerized methods in 
the near future. 
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